Impact of the COVID‐19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries

Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern

(2020)   Eurosurveillance

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

(2020) Cong Ye et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

(2020) Ennio Giulio Favalli et al.   JOURNAL OF RHEUMATOLOGY

The hallmarks of COVID-19 disease

(2020) Daolin Tang et al.   PLoS Pathogens

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients—Lessons Learned From SARS and MERS

(2020) Nora Möhn et al.   Frontiers in Immunology

Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases

(2020) Dalifer D Freites Nuñez et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East

(2019) Mohamed Bedaiwi et al.   RHEUMATOLOGY INTERNATIONAL

Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?

(2012) Bassel El Zorkany et al.   CLINICAL RHEUMATOLOGY